Skip to content

Effects of fentanyl and butorphanol on intragastric pressure in healthy volunteers

Effects of low-dose fentanyl and low-dose butorphanol on esophageal and intragastric pressure in healthy volunteers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021120
Enrollment
Unknown
Registered
2019-01-29
Start date
2019-01-28
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal and intragastric pressure

Interventions

Group 1:Intravenous Fentanyl
Group 2:Intravenous butorphanol

Sponsors

Third Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Volunteers aged 18-40 years old were fasting for 6 hours before the test; 2. Agree to volunteer to participate in the study; 3. good health, no combined digestive tract and cardiovascular disease, no liver and kidney dysfunction.

Exclusion criteria

Exclusion criteria: Obesity with body mass index over 30 kg / m2, pregnancy, drug abuse or alcohol abuse, multiple heartburns per week, history of gastroesophageal reflux or any history of esophageal or gastric surgery. Volunteers take medications that may alter the pressure of the gastroesophageal sphincter, including anticholinergics (including atropine, Glon), dopamine and derivatives, sodium nitroprusside, ganglion blockers, antihistamines, corticosteroids, topical Nicotine, tricyclic antidepressants, beta adrenergic stimulants, opioids and oral contraceptives.

Design outcomes

Primary

MeasureTime frame
esophageal and intragastric pressure;

Countries

China

Contacts

Public ContactCHENG NAN

Third Affiliated Hospital, Sun Yat-sen Universit

952798712@qq.com+86 13631405842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026